Shanghai SynTheAll Pharmaceutical Co., Ltd.
Shanghai SynTheAll Pharmaceutical Co., Ltd., commonly referred to as SynTheAll, is a leading player in the pharmaceutical industry, headquartered in Shanghai, China. Established in 2004, the company has made significant strides in the development and manufacturing of high-quality active pharmaceutical ingredients (APIs) and intermediates, catering to both domestic and international markets. With a strong focus on research and development, SynTheAll offers a diverse range of products, including custom synthesis and contract manufacturing services. Their commitment to innovation and quality has positioned them as a trusted partner for pharmaceutical companies worldwide. Notably, SynTheAll has achieved several milestones in regulatory compliance, ensuring that their products meet stringent international standards. As a result, they have solidified their reputation as a reliable source of pharmaceutical solutions in a competitive landscape.
DitchCarbon Score
How does Shanghai SynTheAll Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shanghai SynTheAll Pharmaceutical Co., Ltd.'s score of 24 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shanghai SynTheAll Pharmaceutical Co., Ltd.'s reported carbon emissions
Shanghai SynTheAll Pharmaceutical Co., Ltd. currently does not have publicly available carbon emissions data for the most recent year. However, the company is actively engaged in climate commitments within the pharmaceutical sector. As of September 2023, they have committed to near-term reduction targets, although specific numerical targets have not been disclosed. The company has not yet set a net-zero commitment, indicating a focus on developing their climate strategy further. Their initiatives align with industry standards, reflecting a growing trend among pharmaceutical companies to address climate change proactively. While specific emissions figures are absent, the commitment to reduction targets suggests a dedication to improving their environmental impact in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shanghai SynTheAll Pharmaceutical Co., Ltd. is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
